HCU Updates

Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria

Synlogic and Ginkgo have announced the nomination of SYNB1353, an investigational Sy…

more

Phase 1/2 COMPOSE Study of pegtibatinase

Travere Therapeutics have announced positive topline results from the ongoing Phase 1…

more

Events

18th May 2022

HCU Network Australia is leading the initiative to launch a global awareness day for the homocystinurias. Details to be released closer to the date.…

more

Videos

View HCU YouTube Channel

Sponsors & Partners